Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LAURA SEVERYN

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family

NPI
1366800468
CMS profile
10825084
Location
NAPLES, FL

General Payments · PY2021–2024

$4,336.41

  • Reported across 60 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,293.00

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,293.00 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $291.28 2
CVRx Inc. $131.39 1
Actelion Pharmaceuticals US, Inc. $123.71 1
GlaxoSmithKline, LLC. $120.85 1
Lilly USA, LLC $118.49 1
Pulmonx Corporation $115.60 1
Abbott Laboratories $112.41 1
Amgen Inc. $94.31 1
Medtronic, Inc. $85.50 2
Insmed, Inc. $53.41 1
IRONSHORE PHARMACEUTICALS INC. $46.05 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $901.33 13
PY2022 $776.46 17
PY2023 $1,365.62 16
PY2024 $1,293.00 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $112.41 12/03/2024 Food and Beverage Undisputed 01/23/2026 1125030127 CMS
Actelion Pharmaceuticals US, Inc. $123.71 03/27/2024 Food and Beverage Undisputed 01/23/2026 1078878142 CMS
Amgen Inc. $94.31 05/16/2024 Food and Beverage Undisputed 01/23/2026 1117379406 CMS
CVRx, Inc. $131.39 09/11/2024 Food and Beverage Undisputed 01/23/2026 1138616391 CMS
GlaxoSmithKline, LLC. $120.85 02/08/2024 Food and Beverage Undisputed 01/23/2026 1116066276 CMS
Insmed, Inc. $53.41 01/10/2024 Food and Beverage Undisputed 01/23/2026 1089574906 CMS
IRONSHORE PHARMACEUTICALS INC. $21.33 07/15/2024 Food and Beverage Undisputed 01/23/2026 1146296922 CMS
IRONSHORE PHARMACEUTICALS INC. $24.72 12/02/2024 Food and Beverage Undisputed 01/23/2026 1146303493 CMS
Janssen Pharmaceuticals, Inc $145.02 03/06/2024 Food and Beverage Undisputed 01/23/2026 1077970442 CMS
Janssen Pharmaceuticals, Inc $146.26 09/24/2024 Food and Beverage Undisputed 01/23/2026 1077970048 CMS
Lilly USA, LLC $118.49 04/18/2024 Food and Beverage Undisputed 01/23/2026 1135763047 CMS
Medtronic, Inc. $61.36 02/01/2024 Food and Beverage Undisputed 01/23/2026 1116939503 CMS
Medtronic, Inc. $24.14 02/05/2024 Food and Beverage Undisputed 01/23/2026 1116939505 CMS
Pulmonx Corporation $115.60 11/21/2024 Food and Beverage Undisputed 01/23/2026 1087854062 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.